首页> Basic Research in Cardiology: Official Journal of the German Association of Cardiovascular Research> HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9.

HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9.

导出原文传递

翻译打印收藏纠错

第一作者： Viedt C

作者： Viedt C ^[1] ; Shen W ^[2] ; Fei J ; Kamimura M ; Hansch GM ; Katus HA ; Kreuzer J

作者单位： Department of Internal Medicine III, University of Heidelberg, Bergheimer Str. 58, 69115, Heidelberg, Germany, christiane_viedt@med.uni-heidelberg.de ^[1] Yarmouk University Irbid - Jordan ^[2]

关键词 Complement Membrane Attack Complex cerivastatin Hydroxymethylglutaryl-CoA-Reductases NADP-dependent 补体膜攻击复合物

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Basic Research in Cardiology

2003年98卷6期

353-361页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览1

Basic Research in Cardiology

2003年98卷6期

353-361页

检索历史清除

HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9.

Basic Research in Cardiology

相似文献

同项目论文

Basic Research in Cardiology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9.

Basic Research in Cardiology

相似文献

同项目论文

Basic Research in Cardiology

相关期刊

检索历史清除